Predictive Oncology has Announced Agreement to be Acquired by Renovaro / cancer, OncoDaily, Oncology, Predictive Oncology, Renovaro

Investing.com -- Predictive Oncology Inc (NASDAQ:POAI) stock fell 4.7% after the AI-driven drug discovery company announced a standby equity purchase agreement with an investment fund managed by Yorkville Advisors Global. The agreement gives Predictive Oncology the right to sell up to $10 million worth of its common stock to YA II PN, LTD, a fund managed by Yorkville Advisors. The company emphasized that it will maintain full control over the timing and amount of any stock sales under the agreement. Predictive Oncology stated that the partnership is intended to provide "an efficient and flexible source of funding" to support its ongoing drug discovery initiatives, biomarker research, and business development opportunities with biopharmaceutical companies. According to the terms disclosed, there are no warrants, derivatives, or other share classes associated with the standby equity purchase agreement. The company is not obligated to use any portion of the $10 million available and faces no minimum commitments or penalties. Additionally, the agreement does not impose any restrictions on Predictive Oncology’s operating activities. The company plans to use any proceeds to advance its artificial intelligence and machine learning capabilities in drug discovery and repurposing efforts. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C. Don't miss out on the next big opportunity! Stay ahead of the curve with ProPicks AI – 6 model portfolios fueled by AI stock picks with a stellar performance this year... In 2024 alone, ProPicks AI identified 2 stocks that surged over 150%, 4 additional stocks that leaped over 30%, and 3 more that climbed over 25%. That's an impressive track record. With portfolios tailored for Dow stocks, S&P stocks, Tech Stocks, and Mid Cap stocks, you can explore various wealth-building strategies. So if POAI is on your watchlist, it could be very wise to know whether or not it made the ProPicks AI lists.